These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15975250)

  • 21. In vitro biotransformation of the selective serotonin reuptake inhibitor citalopram, its enantiomers and demethylated metabolites by monoamine oxidase in rat and human brain preparations.
    Kosel M; Gnerre C; Voirol P; Amey M; Rochat B; Bouras C; Testa B; Baumann P
    Mol Psychiatry; 2002; 7(2):181-8. PubMed ID: 11840311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum concentrations of citalopram--dose-dependent variation in R- and S-enantiomer ratios.
    Tanum L; Strand LP; Refsum H
    Pharmacopsychiatry; 2010 Jul; 43(5):190-3. PubMed ID: 20503148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Routine therapeutic drug monitoring in patients treated with 10-360 mg/day citalopram.
    Le Bloc'h Y; Woggon B; Weissenrieder H; Brawand-Amey M; Spagnoli J; Eap CB; Baumann P
    Ther Drug Monit; 2003 Oct; 25(5):600-8. PubMed ID: 14508384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disposition of citalopram in biological specimens from postmortem cases.
    Jenkins AJ; Gubanich K
    J Forensic Sci; 2002 Jan; 47(1):159-64. PubMed ID: 12064644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enantioselective analysis of citalopram and its metabolites in postmortem blood and genotyping for CYD2D6 and CYP2C19.
    Holmgren P; Carlsson B; Zackrisson AL; Lindblom B; Dahl ML; Scordo MG; Druid H; Ahlner J
    J Anal Toxicol; 2004 Mar; 28(2):94-104. PubMed ID: 15068562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Citalopram distribution in postmortem cases.
    Levine B; Zhang X; Smialek JE; Kunsman GW; Frontz ME
    J Anal Toxicol; 2001 Oct; 25(7):641-4. PubMed ID: 11599616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of quinidine, fluvoxamine, and ketoconazole on the enantioselective pharmacokinetics of citalopram in rats.
    Rocha A; Coelho EB; Lanchote VL
    Can J Physiol Pharmacol; 2008 Nov; 86(11):770-6. PubMed ID: 19011672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and validation of a liquid chromatographic method for determination of enantiomeric purity of citalopram in bulk drugs and pharmaceuticals.
    Nageswara Rao R; Narasa Raju A; Nagaraju D
    J Pharm Biomed Anal; 2006 Apr; 41(1):280-5. PubMed ID: 16321492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma levels of citalopram enantiomers and metabolites in elderly patients.
    Foglia JP; Pollock BG; Kirshner MA; Rosen J; Sweet R; Mulsant B
    Psychopharmacol Bull; 1997; 33(1):109-12. PubMed ID: 9133760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stereoselective metabolism of citalopram in plasma and cerebrospinal fluid of depressive patients: relationship with 5-HIAA in CSF and clinical response.
    Nikisch G; Mathé AA; Czernik A; Eap CB; Jiménez-Vasquez P; Brawand-Amey M; Baumann P
    J Clin Psychopharmacol; 2004 Jun; 24(3):283-90. PubMed ID: 15118482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stereoselective HPLC-assay for citalopram and its metabolites.
    Zheng Z; Jamour M; Klotz U
    Ther Drug Monit; 2000 Apr; 22(2):219-24. PubMed ID: 10774637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The extent of postmortem drug redistribution in a rat model.
    Hilberg T; Ripel A; Slørdal L; Bjørneboe A; Mørland J
    J Forensic Sci; 1999 Sep; 44(5):956-62. PubMed ID: 10486948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Citalopram and demethylcitalopram in human milk; distribution, excretion and effects in breast fed infants.
    Rampono J; Kristensen JH; Hackett LP; Paech M; Kohan R; Ilett KF
    Br J Clin Pharmacol; 2000 Sep; 50(3):263-8. PubMed ID: 10971311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Concentrations of citalopram and escitalopram in postmortem hair segments.
    Rygaard K; Nielsen MKK; Linnet K; Banner J; Johansen SS
    Forensic Sci Int; 2022 Jul; 336():111349. PubMed ID: 35660811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discrimination between patterns of drug exposure by toxicological analysis of decomposed skeletal tissues. Part II: Amitriptyline and citalopram.
    Watterson JH; Cornthwaite HM
    J Anal Toxicol; 2013 Oct; 37(8):565-72. PubMed ID: 23986100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma Concentrations and Cardiovascular Effects of Citalopram Enantiomers After Oral Versus Infusion Citalopram Therapy in Dextromethorphan-Mephenytoin-Phenotyped Patients With Major Depression.
    Baumann P; Bertschy G; Ramseier F; Nil R
    Ther Drug Monit; 2021 Jun; 43(3):436-442. PubMed ID: 33060488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simultaneous analysis of citalopram and desmethylcitalopram by liquid chromatography with fluorescence detection after solid-phase extraction.
    Meng QH; Gauthier D
    Clin Biochem; 2005 Mar; 38(3):282-5. PubMed ID: 15708552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of tobacco smoke on the pharmacokinetics of citalopram and its enantiomers.
    Majcherczyk J; Kulza M; Senczuk-Przybylowska M; Florek E; Jawien W; Piekoszewski W
    J Physiol Pharmacol; 2012 Feb; 63(1):95-100. PubMed ID: 22460466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Steady-state pharmacokinetics of the enantiomers of citalopram and its metabolites in humans.
    Sidhu J; Priskorn M; Poulsen M; Segonzac A; Grollier G; Larsen F
    Chirality; 1997; 9(7):686-92. PubMed ID: 9366029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of citalopram on brain serotonin release in experimental hepatic encephalopathy: implications for thymoleptic drug safety in liver insufficiency.
    Bergqvist PB; Wikell C; Hjorth S; Apelqvist G; Bengtsson F
    Clin Neuropharmacol; 1997 Dec; 20(6):511-22. PubMed ID: 9403225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.